SCYX
Price
$0.73
Change
-$0.01 (-1.35%)
Updated
Jul 25 closing price
Capitalization
55.88M
23 days until earnings call
SGIOY
Price
$8.61
Change
+$0.04 (+0.47%)
Updated
Jul 25 closing price
Capitalization
12.4B
2 days until earnings call
Interact to see
Advertisement

SCYX vs SGIOY

Header iconSCYX vs SGIOY Comparison
Open Charts SCYX vs SGIOYBanner chart's image
SCYNEXIS
Price$0.73
Change-$0.01 (-1.35%)
Volume$62.62K
Capitalization55.88M
Shionogi & Co
Price$8.61
Change+$0.04 (+0.47%)
Volume$45.23K
Capitalization12.4B
SCYX vs SGIOY Comparison Chart in %
Loading...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCYX vs. SGIOY commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCYX is a Hold and SGIOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (SCYX: $0.73 vs. SGIOY: $8.61)
Brand notoriety: SCYX and SGIOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SCYX: 37% vs. SGIOY: 62%
Market capitalization -- SCYX: $55.88M vs. SGIOY: $12.4B
SCYX [@Pharmaceuticals: Other] is valued at $55.88M. SGIOY’s [@Pharmaceuticals: Other] market capitalization is $12.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCYX’s FA Score shows that 0 FA rating(s) are green whileSGIOY’s FA Score has 2 green FA rating(s).

  • SCYX’s FA Score: 0 green, 5 red.
  • SGIOY’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCYX’s TA Score shows that 5 TA indicator(s) are bullish while SGIOY’s TA Score has 6 bullish TA indicator(s).

  • SCYX’s TA Score: 5 bullish, 3 bearish.
  • SGIOY’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SGIOY is a better buy in the short-term than SCYX.

Price Growth

SCYX (@Pharmaceuticals: Other) experienced а +0.70% price change this week, while SGIOY (@Pharmaceuticals: Other) price change was +3.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Reported Earning Dates

SCYX is expected to report earnings on Nov 05, 2025.

SGIOY is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOY($12.4B) has a higher market cap than SCYX($55.9M). SGIOY has higher P/E ratio than SCYX: SGIOY (9.62) vs SCYX (1.06). SGIOY YTD gains are higher at: 23.709 vs. SCYX (-39.661). SGIOY has higher annual earnings (EBITDA): 242B vs. SCYX (70.9M). SGIOY has more cash in the bank: 563B vs. SCYX (74.4M). SCYX has less debt than SGIOY: SCYX (15.1M) vs SGIOY (9.41B). SGIOY has higher revenues than SCYX: SGIOY (427B) vs SCYX (140M).
SCYXSGIOYSCYX / SGIOY
Capitalization55.9M12.4B0%
EBITDA70.9M242B0%
Gain YTD-39.66123.709-167%
P/E Ratio1.069.6211%
Revenue140M427B0%
Total Cash74.4M563B0%
Total Debt15.1M9.41B0%
FUNDAMENTALS RATINGS
SCYX vs SGIOY: Fundamental Ratings
SCYX
SGIOY
OUTLOOK RATING
1..100
611
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
962
PRICE GROWTH RATING
1..100
8952
P/E GROWTH RATING
1..100
9849
SEASONALITY SCORE
1..100
1065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOY's Valuation (27) in the null industry is in the same range as SCYX (53) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's Profit vs Risk Rating (100) in the null industry is in the same range as SCYX (100) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for SCYX (96) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew significantly faster than SCYX’s over the last 12 months.

SGIOY's Price Growth Rating (52) in the null industry is somewhat better than the same rating for SCYX (89) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew somewhat faster than SCYX’s over the last 12 months.

SGIOY's P/E Growth Rating (49) in the null industry is somewhat better than the same rating for SCYX (98) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew somewhat faster than SCYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCYXSGIOY
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
64%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 19 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVGE79.890.21
+0.26%
Avantis All Equity Markets ETF
UAPR31.610.07
+0.24%
Innovator U.S. Equity Ultra BffrETF™-Apr
INCE58.690.07
+0.12%
Franklin Income Equity Focus ETF
ISWN20.650.01
+0.03%
Amplify BlackSwan ISWN ETF
PDI19.11-0.01
-0.05%
PIMCO Dynamic Income Fund

SCYX and

Correlation & Price change

A.I.dvisor tells us that SCYX and AQST have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
-1.07%
AQST - SCYX
33%
Poorly correlated
-1.19%
CRDL - SCYX
30%
Poorly correlated
+2.86%
TLRY - SCYX
30%
Poorly correlated
-2.03%
AKAN - SCYX
29%
Poorly correlated
+0.79%
OGI - SCYX
28%
Poorly correlated
+1.32%
More

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+0.41%
TAK - SGIOY
40%
Loosely correlated
-1.23%
ESAIY - SGIOY
36%
Loosely correlated
-0.28%
KMDA - SGIOY
27%
Poorly correlated
-0.77%
SCYX - SGIOY
23%
Poorly correlated
-1.07%
SUPN - SGIOY
22%
Poorly correlated
+2.22%
More